K
Keith Hawton
Researcher at University of Oxford
Publications - 700
Citations - 61806
Keith Hawton is an academic researcher from University of Oxford. The author has contributed to research in topics: Poison control & Suicide prevention. The author has an hindex of 125, co-authored 657 publications receiving 55138 citations. Previous affiliations of Keith Hawton include Warneford Hospital & St Thomas' Hospital.
Papers
More filters
Journal ArticleDOI
Self-harm and suicide in adolescents.
TL;DR: Major challenges include the development of greater understanding of the factors that contribute to self-harm and suicide in young people, especially mechanisms underlying contagion and the effect of new media.
Journal ArticleDOI
Suicide prevention strategies revisited: 10-year systematic review
Gil Zalsman,Gil Zalsman,Keith Hawton,Danuta Wasserman,Kees van Heeringen,Ella Arensman,Marco Sarchiapone,Vladimir Carli,Cyril Höschl,Ran Barzilay,Judit Balazs,György Purebl,Jean-Pierre Kahn,Pilar A. Saiz,Cendrine Bursztein Lipsicas,Julio Bobes,Doina Cozman,Ulrich Hegerl,Joseph Zohar +18 more
TL;DR: The evidence for restricting access to lethal means in prevention of suicide has strengthened since 2005, especially with regard to control of analgesics and hot-spots for suicide by jumping.
Journal ArticleDOI
A report--chronic fatigue syndrome: guidelines for research.
Michael Sharpe,L. C. Archard,J. E. Banatvala,L. K. Borysiewicz,A. W. Clare,A. David,R. H. Edwards,Keith Hawton,H. P. Lambert,R. J. Lane +9 more
TL;DR: Authors Dr M C Sharpe MRCPsych Clinical Lecturer, Department of Psychiatry, University of Oxford Dr L C Archard PhD Senior Lecturer , Department of Biochemistry, Charing Cross and Westminster Medical School, London
Journal ArticleDOI
Risk factors for suicide in individuals with depression: a systematic review.
TL;DR: A systematic review of the international literature on cohort and case-control studies of people with depression in which suicide was an outcome and meta-analyses of potential risk factors found factors significantly associated with suicide.
Journal ArticleDOI
Suicide risk and prevention during the COVID-19 pandemic.
David Gunnell,Louis Appleby,Ella Arensman,Keith Hawton,Ann John,Nav Kapur,Murad M. Khan,Rory C. O'Connor,Jane Pirkis,Eric D. Caine,Lai Fong Chan,Shu-Sen Chang,Ying-Yeh Chen,Helen Christensen,Rakhi Dandona,Michael Eddleston,Annette Erlangsen,Jill M. Harkavy-Friedman,Olivia J. Kirtley,Duleeka Knipe,Duleeka Knipe,Flemming Konradsen,Shiwei Liu,Sally McManus,Lars Mehlum,Matthew J. Miller,Paul Moran,Jacqui Morrissey,Christine Moutier,Thomas Niederkrotenthaler,Merete Nordentoft,Siobhan O'Neill,Andrew Page,Michael Phillips,Steve Platt,Maurizio Pompili,Ping Qin,Mohsen Rezaeian,Morton M. Silverman,Mark Sinyor,Steven Stack,Ellen Townsend,Gustavo Turecki,Lakshmi Vijayakumar,Paul S. F. Yip +44 more
TL;DR: The promise of targeting the inflammation pathway in the management of this challenging condition is today somewhat weaker, but this might not be the last word on the potential role of anti-inflammatory drugs in the treatment of bipolar depression.